|

VK-2019 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Thomas Jefferson University1

Indications

  • Epstein-Barr Virus (EBV) Infection1
  • Diffuse Large B Cell Lymphoma Relapsed1
  • Diffuse Large B Cell Lymphoma Refractory1
  • Cancer1

Philadelphia, Pennsylvania1 trial

A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)

Honickman Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.